TETRAPHASE PHARMACEUTICALS INC: cash_and_equivalents

Value{"amount": 107776000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2018-12-31)
Statuscurrent
EntityTETRAPHASE PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-19-008034 · Open the official SEC filing →
Retrieved: 2026-08-19T13:11:20.304535+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001373707/cash-and-equivalents/2018-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/8a18581e-e11d-4879-a68d-dfbbb116080a

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies